FSL2 Post Approval Study for Pediatric and Young Adults Patients

Running, not enrolling

Conditions studied: Diabete Mellitus

In brief

This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of the FreeStyle Libre 2 Flash Glucose Monitoring System when used to manage diabetes in pediatric and young adult patient populations.

Key facts

Study ID

NCT04959552

Run by

Abbott Diabetes Care

People needed

550

Starts

2021-06-01

Expected to finish

2026-12-30

Last updated by the study team

2026-04-09

Who can join

Age: 4 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must be 4 - 30 years of age.
• Subject must have a diagnosis of type 1 or type 2 diabetes mellitus for at least 3 months prior to enrollment.
• Subject is currently using Self Monitoring of Blood Glucose (SMBG) for managing their diabetes.
• Subject has completed participation in clinical study ADC-US-PMS-20194 or has at least six (6) months of medical history hypoglycemia or hyperglycemia requiring healthcare professional intervention.
• Subject and/or caregiver must be able to read and understand English.
• In the investigator's opinion, the subject and/or caregiver must be able to follow the instructions provided to him/her by the study site and perform all study tasks as specified by the protocol.
• Subject and/or parent or guardian must be willing and able to provide written signed and dated informed consent and assent when appropriate.

You may not qualify if…

• Subject has previously used a continuous glucose monitoring system to manage their diabetes within the last six (6) months.
• Subject has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin.
• Subject is known to be pregnant or is attempting to become pregnant at the time of enrollment.
• Subject is on dialysis at the time of enrollment.
• Subject has concomitant medical condition which, in the opinion of the investigator, could interfere with the study or present a risk to the safety or welfare of the subject or study staff.
• Subject currently is participating in another clinical trial.
• Subject is unsuitable for participation due to any other cause as determined by the Investigator.

Where it is running

• Yale Pediatric Endocrinology Clinic — New Haven, Connecticut, United States
• The Children's Mercy Hospital — Kansas City, Missouri, United States
• The DOCS — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.